WESTFORD, Mass., June 8, 2011 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that former Babson College President Brian M. Barefoot has been elected to the Company's board of directors.
Barefoot, 68, becomes the fourth independent director on Cynosure's seven-member board, filling a vacancy. He will serve on the Company's Audit and Corporate Governance committees.
Currently, Barefoot serves on the board of directors of Blue Cross Blue Shield of Massachusetts, where he is Chair of the Audit Committee and a member of the Finance and Business Performance Committee. In addition, he is a director of Array Health Solutions Inc., a health care technology and services company based in Seattle; and a senior advisor to Carl Marks & Co. LP, a New York-based middle market merchant bank."Brian brings to the Board an outstanding reputation as a financial executive and a business leader," said Cynosure Chairman, President and CEO Michael Davin. "We believe that Brian's corporate governance expertise, combined with his leadership skills and experience over more than three decades in financial services, enables him to provide valuable strategic insight as a member of our board." Barefoot served as Babson College president from 2001 to 2008, and as chairman of the board of trustees from 1996 to 2001. Under his leadership, Babson continued to strengthen the innovative programs for undergraduate students, MBA students and business professionals that have consistently earned the college #1 rankings for entrepreneurship. Upon Barefoot's retirement from Babson, he was elected president emeritus. A graduate of Babson, Barefoot joined the school's governing board in 1985 and served in numerous capacities, including Chair of the Investment Committee, Chair of the Development and Alumni Relations Committee and Chair of the Executive Committee.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts